32 / 94
32
Ces Urol 2015; 19(1): 19–32
PŘEHLEDOVÝ ČLÁNEK
31. Kiltie AE, Elwell C, Close HJ, et al.
Iridium-192 implantation for node-negative carcinoma of the penis.
Clin Oncol 2000; 12: 25–31.
32. Mazeron JJ, Langlois D, Lobo PA, et al.
Interstitial radiation therapy for carcinoma of the penis using
iridium -192 wires. The Henri Mondor experience (1970–1979) Int J Radiat Oncol Biol Phys 1984; 10: 1891–1895.
33. Rozan R, Albuisson E, Giraud B, et al.
Interstitial brachytherapy for penile carcinoma; a multicentric
survey (259 patients), Radiother Oncol 1995; 36: 83–93.
34. Suchaud JP, Kantor G, Richard P, et al.
Brachytherapy of the cancer of the penis. Analysis of a series
of 53 cases. J Urol 1989; 95: 27–31.
35. Crook JM, Haie-Meder C, Demanes DJ, et al.
American Brachytherapy Society-Groupe Europeén de
Curiethérapie- European Society of Therapeutic Radiation Oncology (ABC-GEC-ESTRO) consensus statement
for penile brachytherapy. Brachytherapy 2013; 12: 191–198.
36. Petera J, Odrazka K, Zouhar M, et al.
High-dose rate interstitial brachytherapy for the treatment of
penile carcinoma. Strahhlenter Oncol 2004; 180: 123–125.
37. Pagliaro LC, Williams DL, Daliani D, et al.
Neoadjuvant paclitaxel, ifosfamid, and cisplatin chemotherapy
for metastatic penile cancer: A phase II study. J Clin Oncol, 2010; (28)24: 3851–3857.
38. Ahmed T, Sklarof R, Yagoda A.
An appraisal of the efficacy of bleomycin in epidermoid carcinoma of
the penis. Anticancer res 1984; 4: 289–292.
39. Garnick MB, Skarin AT, Steele GD.
Metastatic carcinoma of the penis: complete remission after high
dose methotrexate chemotherapy. J Urol 1979; 122: 265–266.
40. Shammas FV, Ous S, Fossa SD.
Cisplatin and 5-fluorouracil in advanced cancer of the penis. J Urol
1992; 147: 630–632.
41. Theodore C, Skoneczna I, Bodrogi I, et al.
A phase II multicentre study of irinotecan in combination
with cisplatin in metastatic or locally advanced penile carcinoma (EORTC protocol 30992). Ann Oncol
2008; 19: 1304–1307.
42. Kattan J, Culine S, Droz JP, et al.
Penile cancer chemotherapy: Twelve years experience at Institut
Gustave-Roussy. UROLOGY 1993; 42(5): 559–563.
43. Pizzocaro G, Piva L, Bandieramonte G, et al.
Up-to-date management of carcinoma of the penis. Eur
Urol 1997; 32: 5–15.
44. Dexeus FH, Logothetis CJ, Sella A, et al.
Combination of chemotherapy with methotrexate, bleomycin
and cisplatin for advanced squamous cell carcinoma of the male genital tract. J Urol 1991; 146: 1284–1287.
45. Bermejo C, Busby JE, Spiess PE, et al.
Neoadjuvant chemotherapy followed by aggressive surgical
consolidation for metastatic penile squamous cell carcinoma. J Urol 2007; 177: 1335–1338.
46. DiLorenzo G, Federico P, Buonerba C, et al.
Paclitaxel in pretreated metastatic penile cancer: final
results of a phase 2 study. Eur Urol 2011; 60: 1280–1284.
47. Pizzocaro G, Nicolai N, Milani A.
Taxanes in combination with cisplatin and fluorouracil for advanced
penile cancer: preliminary results. Eur Urol 2009; 55: 546–551.